Literature DB >> 24724042

A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.

Rodrigo D Perea1, Rebecca C Rada2, Jessica Wilson3, Eric D Vidoni12, Jill K Morris4, Kelly E Lyons5, Rajesh Pahwa5, Jeffrey M Burns4, Robyn A Honea1.   

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are among the most common neurodegenerative disorders affecting older populations. AD is characterized by impaired memory and cognitive decline while the primary symptoms of PD include resting tremor, bradykinesia and rigidity. In PD, mild cognitive changes are frequently present, which could progress to dementia (PD dementia (PDD)). PDD and AD dementias are different in pathology although the difference in microstructural changes remains unknown. To further understand these diseases, it is essential to understand the distinct mechanism of their microstructural changes. We used diffusion tensor imaging (DTI) to investigate white matter tract differences between early stage individuals with AD (n=14), PD (n=12), PDD (n=9), and healthy non-demented controls (CON) (n=13). We used whole brain tract based spatial statistics (TBSS) and a region of interest (ROI) analysis focused on the substantia nigra (SN). We found that individuals with PDD had more widespread white matter degeneration compared to PD, AD, and CON. Individuals with AD had few regional abnormalities in the anterior and posterior projections of the corpus callosum while PD and CON did not appear to have significant white matter degeneration when compared to other groups. ROI analyses showed that PDD had the highest diffusivity in the SN and were significantly different from CON. There were no significant ROI differences between CON, PD, or AD. In conclusion, global white matter microstructural deterioration is evident in individuals with PDD, and DTI may provide a means with which to tease out pathological differences between AD and PD dementias.

Entities:  

Keywords:  Cingulum; Corpus callosum; Corticospinal tract; Dementia; Neurodegenerative disorders

Year:  2013        PMID: 24724042      PMCID: PMC3979316          DOI: 10.4172/2161-0460.1000123

Source DB:  PubMed          Journal:  J Alzheimers Dis Parkinsonism


  55 in total

Review 1.  Understanding higher level gait disturbances in mild dementia in order to improve rehabilitation: 'last in-first out'.

Authors:  Erik Scherder; Laura Eggermont; Chris Visscher; Philip Scheltens; Dick Swaab
Journal:  Neurosci Biobehav Rev       Date:  2010-09-15       Impact factor: 8.989

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

Review 4.  Design, analysis, and interpretation of method-comparison studies.

Authors:  Sandra K Hanneman
Journal:  AACN Adv Crit Care       Date:  2008 Apr-Jun

Review 5.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

6.  Lewy body dementia and Parkinson's disease with dementia.

Authors:  Richard Dodel; Ilona Csoti; Georg Ebersbach; Gerd Fuchs; Matthias Hahne; Wilfried Kuhn; Matthias Oechsner; Wolfgang Jost; Heinz Reichmann; Jörg B Schulz
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

7.  White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

Authors:  G Gattellaro; L Minati; M Grisoli; C Mariani; F Carella; M Osio; E Ciceri; A Albanese; M G Bruzzone
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-02       Impact factor: 3.825

Review 8.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

9.  Case control study of diffusion tensor imaging in Parkinson's disease.

Authors:  L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

10.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

View more
  12 in total

Review 1.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 2.  Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.

Authors:  Fabiana C C Hirata; João R Sato; Gilson Vieira; Leandro T Lucato; Claudia C Leite; Edson Bor-Seng-Shu; Bruno F Pastorello; Maria C G Otaduy; Khallil T Chaim; Kenia R Campanholo; Natalia P Novaes; Luciano Magalhães Melo; Márcia R Gonçalves; Felipe Barjud Pereira do Nascimento; Manoel Jacobsen Teixeira; Egberto Reis Barbosa; Edson Amaro; Ellison Fernando Cardoso
Journal:  Eur Radiol       Date:  2016-10-05       Impact factor: 5.315

3.  Phase Image Texture Analysis for Motion Detection in Diffusion MRI (PITA-MDD).

Authors:  Nahla M H Elsaid; Jerry L Prince; Steven Roys; Rao P Gullapalli; Jiachen Zhuo
Journal:  Magn Reson Imaging       Date:  2019-07-15       Impact factor: 2.546

4.  Microstructural white matter alterations in patients with drug induced parkinsonism.

Authors:  Yoonju Lee; Yong Ho Choi; Jae Jung Lee; Hye Sun Lee; Young H Sohn; Jong-Min Lee; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2017-09-12       Impact factor: 5.038

5.  White matter hypoperfusion and damage in dementia: post-mortem assessment.

Authors:  Seth Love; J Scott Miners
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

6.  Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra.

Authors:  Beatriz Raposo Corradini; Priscila Iamashita; Edilaine Tampellini; José Marcelo Farfel; Lea Tenenholz Grinberg; Carlos Alberto Moreira-Filho
Journal:  Biomed Res Int       Date:  2014-11-26       Impact factor: 3.411

7.  A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease.

Authors:  Xiao-Yan Deng; Li Wang; Ting-Ting Yang; Rui Li; Gang Yu
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

8.  Correction for Eddy Current-Induced Echo-Shifting Effect in Partial-Fourier Diffusion Tensor Imaging.

Authors:  Trong-Kha Truong; Allen W Song; Nan-Kuei Chen
Journal:  Biomed Res Int       Date:  2015-08-30       Impact factor: 3.411

9.  A novel method for evaluating brain function and microstructural changes in Parkinson's disease.

Authors:  Ming-Fang Jiang; Feng Shi; Guang-Ming Niu; Sheng-Hui Xie; Sheng-Yuan Yu
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

10.  Fixel-based analysis reveals fiber-specific alterations during the progression of Parkinson's disease.

Authors:  Yanxuan Li; Tao Guo; Xiaojun Guan; Ting Gao; Wenshuang Sheng; Cheng Zhou; Jingjing Wu; Min Xuan; Quanquan Gu; Minming Zhang; Yunjun Yang; Peiyu Huang
Journal:  Neuroimage Clin       Date:  2020-07-20       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.